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weight (LW/BW)and heart weight/ tibial length (HW/TL) were used
to assess the cardiopulmonary damage caused by pressure overload.
In the histological analysis, HE stain was used to evaluate the cross-
sectional area (CSA) of cardiomyocytes, and PSR stain was used to
evaluate the collagen volume of left ventricle. Real Time PCR was
used in the detection of mRNA expression levels of hypertrophic
and ﬁbrotic markers. To ﬁnd a possible mechanism, the phospho-
protein levels of possible signaling pathways were detected by
Western Blot.
RESULTS As results, HW/BW and HW/TL were elevated after AB,
but less obviously in TMZ group. LW/BW has no signiﬁcant change
after AB. In echocardiography, left ventricle end-diastolic diameter
(LVEDD) and left ventricle end-systolic diameter (LVESD) were
raised after AB, and more remarkably in Placebo group. Ejection
fraction (EF) and fractional shorten (FS) were declined after AB, but
descended less obviously in TMZ group. In the histological analysis,
HE stain indicated the CSA of cardiomyocytes in TMZ group was
ascended less remarkably after AB. Besides, PSR stain show that the
collagen volume in TMZ group has a same tendency. In the detec-
tion of RT-PCR, the mRNA levels of ANP, BNP and b-MHC in TMZ
group were raised much slightly after AB, and ﬁbrotic markers, like
CTGF, TGF-b2, Collagen Ia and Collagen III, have same tendencies.
In the mechanism research, the phospho-protein levels in AKT
signaling pathway, such as p-AKT, p-mTOR, p-4EBP1, p-eIF4e and,
have been changed after AB, and TMZ inhibits the activation of AKT
signaling pathway.
CONCLUSIONS Through the inhibition of cardiac hypertrophy and
ﬁbrosis, TMZ presents a protective effect on cardiac remodeling via
the suppression of AKT signaling pathway. TMZ is probably a poten-
tial therapeutic drug for cardiac remodeling.
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OBJECTIVES APC is a tumor suppressor gene that is involved in the
processes of migration and adhesion, transcriptional activation, and
apoptosis. The goal of this study is to evaluate the contribution of APC
rs383830 polymorphism to coronary heart disease (CHD) in Han
Chinese.
METHODS A total of 783 CHD patients and 737 controls were tested in
the current association study.
RESULTS No signiﬁcant difference of rs383830-T allele between cases
and controls are observed (20.2% versus 18.2%, c2 ¼ 1.950, df ¼ 1, p ¼
0.163, OR ¼ 1.138, 95% CI ¼ 0.949-1.363). APC rs383830 polymorphism
and CHD, a breakdown analysis by gender indicated there was a sig-
niﬁcant contribution of rs383830-T allele to the risk of CHD in males
(p ¼ 0.046, odds ratio ¼ 1.267, 95% conﬁdential interval ¼ 1.004 -
1.598).
CONCLUSIONS In conclusion, our study suggested a male-speciﬁc
association of APC rs383830 polymorphism with CHD.
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OBJECTIVES Pulmonary arterial hypertension (PAH), which mostly
happens among young people, is associated with high mortality due
to right ventricular failure. Sphingosine-1-phosphate (S1P) is a bioac-
tive sphingolipid metabolite. Previous studies indicate that S1P is
increased in PAH patients and animals and may promote PAH. S1P
lyase (SPL) is the only enzyme that irreversibly degrades S1P. The aims
of our study are to: (1) determine whether SPL is decreased in PAH; (2)
identify the role of SPL in PAH.
METHODS Adult male SPL transgenic (SPL TG) mice and their wild-
type (WT) counterparts were randomly subjected to the followinggroups: WT - normoxia, WT-hypoxia, WT – normoxia þ THI (a speciﬁc
inhibitor of SPL, fed in drinking water, 25mg/L), WT - hypoxiaþTHI,
SPL TG - normoxia, SPL TG-hypoxia. The mice of hypoxia groups were
kept in a chamber which mimics the condition of an altitude of 5000
meters for 16 hours per day. After 8 weeks, the right ventricular free
wall thickness (RVWT) by echocardiography and the weight ratio of
right ventricle to left ventricle plus septum (RV / (LVþS)) were used
to assess right ventricular hypertrophy. We used HE staining of left
lung sagittal sections to calculate (2  wall thickness/external
diameter) 100% (%MWT) of pulmonary arteries to evaluate distal
pulmonary arterial remodeling. Western blot and real-time PCR were
used to examine SPL expression and phosphorylated ERK1/2. S1P
levels in plasma and lung were examined by ELISA.
RESULTS Compared with WT - normoxia group, mice of WT - hyp-
oxia group showed evident PAH, as evidenced by increased RVWT
(0.8570.039 mm vs. 0.5550.075 mm, P <0.01), RV / (LVþS)
(0.2820.017 vs. 0.1980.013, P <0.05), and %MWT (0.3520.021 vs.
0.2140.014, P <0.05, WT - hypoxia group vs. WT - normoxia group).
Moreover, SPL protein and mRNA levels were signiﬁcantly
decreased, while S1P level was signiﬁcantly increased in lung tissue
of mice in WT - hypoxia group (all P <0.05). Compared with WT -
hypoxia group, THI treatment signiﬁcantly increased plasma S1P
level and exacerbated pulmonary arterial remodeling and right
ventricular hypertrophy (all P <0.05, WT – hypoxia þ THI group vs.
WT - hypoxia group). Western blot showed that THI treatment
increased ERK1/2 phosphorylation in lung tissue after hypoxia
exposure (P <0.05). In contrast, SPL TG mice showed remarkably
lower levels of plasma and lung S1P (both P <0.05) and alleviated
pulmonary arterial remodeling and right ventricular hypertrophy
(RVWT: 0.6260.063 mm vs. 0.8570.039mm; RV/(LVþS):
0.2140.015 vs. 0.2820.017; %MWT: 0.2450.017 vs. 0.3520.021;
all P <0.05, SPL TG-hypoxia group vs. WT - hypoxia group). More-
over, SPL overexpression signiﬁcantly reduced phosphorylated
ERK1/2 in lung tissue after hypoxia exposure (P <0.05).
CONCLUSIONS These data indicate that SPL downregulation con-
tributes to increased S1P level and ERK1/2 activation in the progres-
sion of hypoxia-induced PAH. SPL might be a potential therapeutic
target in PAH treatment.GW26-e4709
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OBJECTIVES The aim of the present study was to investigate
whether EGCG could also inhibit PM2.5-induced oxidative stress by
activating the nuclear factor E2-related factor 2 (Nrf2)/heme oxy-
genase-1 (HO-1) pathway in human umbilical vein endothelial cells
(HUVECs).
METHODS The effects of EGCG on PM2.5-induced reduction of
HUVECs viability were evaluated using CCK-8 assays, and the
viability of untreated HUVECs was taken as 100%. The effect of
EGCG reduced PM2.5-induced ROS production in HUVECs was
determined using ﬂow cytometry and confocal ﬂuorescence micro-
scopy after DCFH2-DA staining. The inhibiting effect of ERK1/2 and
p38 MAPK abrogated EGCG-induced Nrf2 and HO-1 expression in
PM2.5-treated HUVECs were determined using Western Blotting
and Real-Time PCR. Nrf2 silencing was designed to demonstrate the
key role of Nrf2 in EGCG-induced Nrf2 and HO-1 upregulation in
PM2.5-treated HUVECs.
RESULTS CCK-8 assays demonstrated that 200, 300, and 400 mg/mL
PM2.5 reduced HUVECs viability to 51.24%  6.90%, 45.97%  6.64%,
and 38.32%  4.89%, respectively; the IC50 value was w200 mg/mL.
DCFH2-DA staining showed that 200 mg/mL PM2.5 tripled ROS pro-
duction (3.20  0.08 vs 1.00  0.12, p < 0.05). At 100 mM, EGCG alone
did not affect ROS production signiﬁcantly, but abolished the PM2.5-
induced increased of ROS production completely. Western blotting
showed that 50 and 100 mg/mL PM2.5 increased Nrf2 expression to
162.6% and 267.3% and increased HO-1 expression to 230.0% and
394.9%, respectively. In contrast, at 200, 300, and 400 mg/mL, PM2.5
decreased Nrf2 expression to 57.6%, 6.4%, and 2.7%, and decreased
HO-1 expression to 41.6%, 19.7%, and 11.7%, respectively. Real time
